Table 1.

The experimental groups and treatments

Group	Medium	Treatment
Control	Osteogenic differentiation medium	No
MO	Osteogenic differentiation medium + 10% Moringa leaf-containing serum	No
OS + H2O2	Osteogenic differentiation medium	100 μmol/L H2O2
MO + H2O2	Osteogenic differentiation medium + 10% Moringa leaf-containing serum	100 μmol/L of H2O2
MO + H2O2 + Wor	Osteogenic differentiation medium + 10% Moringa leaf-containing serum	100 μmol/L H2O2 and 0.5 μmol/L wortmannin
MO + H2O2 + DMSO	Osteogenic differentiation medium + 10% Moringa leaf-containing serum	100 μmol/L H2O2, 0.5 μmol/L of wortmannin and DMSO (its dosage was the same as the MO + H2O2 + Wor group)

OS the third passage of BMSCs were cultured in osteogenic differentiation medium, MO the third passage of BMSCs were cultured in osteogenic differentiation medium + 10% Moringa leaf-containing serum, Wor wortmannin, an inhibitor of PI3K, DMSO solvent of wortmannin